Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Manufacturing methods for producing anti-TNF antibody compositions

Manufacturing methods for producing anti-TNF antibody compositions

US Patent 12180271 · Granted Dec 31, 2024

Estimated economic value: $285,473,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNA polymerase variants for co-transcriptional capping2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024